NCI-MATCH (Molecular Analysis for Therapy Choice) – a national signal finding trial.

Authors

null

Barbara A. Conley

National Cancer Institute, Rockville, MD

Barbara A. Conley , Alice P. Chen , Peter J. O'Dwyer , Carlos L. Arteaga , Stanley R. Hamilton , Paul M. Williams , Richard F. Little , Naoko Takebe , David Patton , Kamalia Sazali , Jeffrey Zhang , James A. Zwiebel , Edith P. Mitchell , Robert James Gray , Lisa McShane , Shuli Li , Larry Rubinstein , Keith Flaherty

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics

Track

Developmental Therapeutics and Translational Research

Sub Track

Small Molecules

Clinical Trial Registration Number

NCT02465060

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS2606)

DOI

10.1200/JCO.2016.34.15_suppl.TPS2606

Abstract #

TPS2606

Poster Bd #

298b

Abstract Disclosures

Similar Posters

Poster

2014 ASCO Annual Meeting

Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.

Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.

First Author: Lindsay Carol Overton

Poster

2018 ASCO Annual Meeting

Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.

Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.

First Author: Razelle Kurzrock

Poster

2017 ASCO Annual Meeting

The scope of possible combination therapy with immunotherapy and targeted therapy.

The scope of possible combination therapy with immunotherapy and targeted therapy.

First Author: Leandro Machado Colli